Patent classifications
A61K8/676
TOPICAL COMPOSITION CONTAINING ASCORBIC ACID AND/OR SALT THEREOF
Provided is a very stable topical composition. A topical composition is prepared that contains (A) from 1 to 40% by mass of at least one type selected from the group consisting of ascorbic acid and salts of ascorbic acid; (B) at least 20% by mass of a diol having three carbon atoms; (C) at least one type selected from the group consisting of tocopherol, salts of tocopherol, and derivatives of tocopherol; and (D) water, wherein the mass ratio of component (D) to component (A) is from 0.5 to 5.0 and the topical composition includes less than 20% by mass of glycol ether.
Edible Oral Compositions Comprising Hops
Edible oral compositions including hops and calcium. Edible oral compositions including hops and tin. Edible oral compositions that are free of fluoride. Edible oral compositions which are gummy compositions, chewable compositions, pan-chew composition, tablet compositions, dissolving tablet compositions, dissolving films, leave-on compositions, lollipop compositions, lozenge compositions, nonwoven fiber compositions, soluble foam compositions, liquid compositions, paste compositions, chewing gum composition, or combinations thereof.
Synergistic Compositions That Reduce UV-Induced Lipid Peroxidation, Formulations and Related Methods
Disclosed is a composition of a synergistically effective ratio of an hydroxamic acid, salt and/or a complex thereof and an antioxidant. The composition is effective to reduce or prevent lipid peroxidation upon exposure of a lipid to UV light. Personal care and other formulations are included within the scope of the invention, as are the related methods of increasing the antioxidant potential of an antioxidant, of reducing a rate of peroxidation of constituent lipids in a personal care formulation over a time period and of reducing peroxidation of lipids within mammalian skin cells.
COSMETIC COMPOSITIONS AND USES THEREOF
The invention features cosmetic compositions comprising Swertia chirata extract and hydrolyzed Ceratonia siliqua seed extract formulated for topical administration and their related uses, e.g., for reducing skin aging or wrinkles.
Optimized skincare regimens for changing the genetic skin type to the ideal skin type—oily, resistant, non-pigmented and tight skin
Methods of improving (i.e., changing) the skin of a patient or consumer who does not have sensitive, dry, very oily, pigmented and/or wrinkle-prone skin to slightly oily, resistant non-pigmented and tight skin.
Skin Compositions and Uses
The present invention provides a skin care composition for maintaining or improving the healthy appearance of the skin of an individual and/or rejuvenate the skin of an individual. A skin care composition comprises active ingredients, including, without limitation, growth factors, anti-oxidants, curcuminoids, oils and/or red rice extracts. Among the growth factors comprising biologically active ingredients of the skin care composition are insulin like growth factor (IGF), an epidermal growth factor protein (EGFP), an insulin-like growth factor (IGF), a transforming growth factor beta (TGFβ), and erythropoiesis stimulating agent (ESA). The invention further provides a skin care composition for topical use to maintain or improve the health of the skin of an individual and/or rejuvenate the skin of an individual.
Manufacturing method of an ascorbic acid dispersion material
A manufacturing method of an ascorbic acid dispersion material includes a heating step of adding an ascorbic acid into a solvent including one or more selected from the group consisting of glycerin, diglycerin, polyglycerin represented by a following formula, and propylene glycol, and heating the ascorbic acid to a predetermined temperature to dissolve the ascorbic acid; a cooling step of cooling a solution with the ascorbic acid dissolved therein at a cooling rate of 5 to 20° C./min until a temperature of the solution reaches 35 to 50° C. to remove heat from the solution; and a growth step of storing the solution after completion of the cooling step at 27 to 38° C. for a predetermined period to promote crystal growth so that the ascorbic acid crystal has a flat plate shape, a thickness of 0.05 to 3 μm, and an average particle diameter of 50 to 100 μm. ##STR00001##
COMPOSITION FOR DYEING KERATIN FIBRES AND USE THEREOF
A dye kit comprising: (A) a dyeing composition (A) and (B) a pyrazolone composition (B) comprising a retarding combination of pyrazolone compound and a reducer.
APPARATUS FOR FORMING DELIVERY PATH FOR COMPOSITION FOR TREATMENT AND AUXILIARY ASSEMBLY FOR SKIN TREATMENT INCLUDING SAME
The present invention relates to an apparatus for forming a delivery path for a composition for treatment and an auxiliary assembly for skin treatment including the same, and provides an apparatus for forming a delivery path for a composition for treatment and an auxiliary assembly for skin treatment including the same, the apparatus comprising: a light source; a light irradiating unit for receiving a light from the light source to irradiate the light on a surface of skin; and a control unit for controlling a pulse waveform of a light irradiated through the light irradiating unit so as to form a plurality of pores, which form a path through which a composition applied on the surface of the skin is transferred inside, on the surface of the skin after irradiating the light.
Skin collagen production-promoting agent
A problem of the present invention is to provide a skin collagen production-promoting agent without safety problems. Another problem of the present invention is to provide a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product containing such a substance. TGF-β and/or a TGF-β degradation product, which is acquired by degrading TGF-β with a protease such as pepsin, pancreatin, etc., are used as a skin collagen production-promoting agent or the active ingredient of a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product. The aforementioned TGF-β and/or TGF-β degradation product have an effect of increasing the collagen content of the skin.